Produkty 106647-14-7
CAS 106647-14-7 występuje w naszej ofercie pod nazwami: Matairesinol 4'–O–β–gentiobioside, Matairesinol 4'-O-b-gentiobioside, (3R-trans)-3-[[4-[(6-O-β-D-Glucopyranosyl-β-D-glucopyranosyl)oxy]-3-methoxyphenyl]methyl]dihydro-4-[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone, ≥98%, ≥98%, Matairesinol 4′-O-β-D-glucopyranoside, 98.98%. Oferty producentów: GLPBio, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 10mg, 1mg, 5mg, 20mg, 50mg, 100mg, 200mg, 5 mg.
(3R,4R)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-[[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]methyl]oxolan-2-one (CAS 106647-14-7) to związek chemiczny o wzorze sumarycznym C32H42O16 i masie molowej 682.7 g/mol. Nazwa systematyczna IUPAC: (3R,4R)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-[[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]methyl]oxolan-2-one. InChIKey: SSZQYOJANKKXOX-QFYIXHTHSA-N.
| Wzór sumaryczny | C32H42O16 |
|---|---|
| Masa molowa | 682.7 g/mol |
| Nazwa IUPAC | (3R,4R)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-[[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]methyl]oxolan-2-one |
| InChIKey | SSZQYOJANKKXOX-QFYIXHTHSA-N |
| SMILES | COC1=C(C=CC(=C1)C[C@H]2COC(=O)[C@@H]2CC3=CC(=C(C=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)O)OC)O |
Dane obliczone przez PubChem (NCBI)
Synonimy:
Matairesinol 4'-O-beta-gentiobioside, Matairesinol 4 inverted exclamation marka-O-|A-D-glucopyranoside, Matairesinol 4'-O-beta-D-glucopyranoside, orb1684424, orb1940926, Matairesinol 4'-O-ss-gentiobioside, Matairesinol4'-O-beta-gentiobioside, Matairesinol 4'-O-|?-D-glucopyranoside, Matairesinol 4'-O-|A-D-glucopyranoside